Cargando…
Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
Toll-like receptors (TLRs) have been described as major components of the innate immune system, recognizing the conserved molecular structures found in the large groups of pathogens called pathogen-associated molecular patterns (PAMPs). TLR expression is ubiquitous, from epithelial to immunocompeten...
Autores principales: | Wolska, Anna, Lech-Marańda, Ewa, Robak, Tadeusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SP Versita
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275910/ https://www.ncbi.nlm.nih.gov/pubmed/19096763 http://dx.doi.org/10.2478/s11658-008-0048-z |
Ejemplares similares
-
Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases
por: Robak, Tadeusz, et al.
Publicado: (2009) -
Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
por: Klonowska-Szymczyk, Agnieszka, et al.
Publicado: (2014) -
Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis
por: Kauppila, Joonas H., et al.
Publicado: (2013) -
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
por: Wolska-Washer, Anna, et al.
Publicado: (2023) -
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
por: Wolska-Washer, Anna, et al.
Publicado: (2019)